What is R+D Custom Automation?
R+D Custom Automation operates at the intersection of precision engineering and life sciences, providing bespoke automation systems tailored for the rigorous demands of pharmaceutical and medical device production. The company specializes in the design and deployment of complex manufacturing solutions, ranging from automated assembly for IV bags and syringes to high-throughput systems for diagnostic test kits. By prioritizing regulatory compliance and manufacturing excellence, R+D Custom Automation serves as a vital partner for firms seeking to optimize production efficiency while maintaining the stringent quality standards required by global health authorities. Their technical expertise allows clients to navigate the complexities of scaling production without compromising on safety or precision.
How much funding has R+D Custom Automation raised?
R+D Custom Automation has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in R+D Custom Automation
PPP
Public-Private Partnership
What's next for R+D Custom Automation?
With the successful acquisition of this late-stage capital, R+D Custom Automation is poised to transition into a phase of aggressive market expansion and technological refinement. The strategic roadmap likely involves scaling their engineering teams to meet the rising demand for automated diagnostic and pharmaceutical manufacturing infrastructure. Furthermore, the company is expected to leverage this backing to enhance its R&D initiatives, focusing on next-generation robotics and integrated software solutions that drive manufacturing agility. As the life sciences industry continues to prioritize supply chain resilience and localized production, R+D Custom Automation remains a key player in facilitating the transition toward fully digitized and automated manufacturing environments.
See full R+D Custom Automation company page
